Physical partner violence and Medicaid utilization and expenditures

被引:64
|
作者
Coker, AL [1 ]
Reeder, CE
Fadden, MK
Smith, PH
机构
[1] Univ Texas, Sch Publ Hlth, Discipline Epidemiol, Hlth Sci Ctr, Houston, TX 77030 USA
[2] Univ S Carolina, Coll Pharm, Dept Pharmaceut & Hlth Outcome Sci, Columbia, SC 29208 USA
[3] Univ N Carolina, Dept Publ Hlth Educ, Greensboro, NC 27412 USA
关键词
D O I
10.1016/j.phr.2004.09.005
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. Little research has addressed differences in health care expenditures among women who are currently experiencing intimate partner violence (IPV) compared with those who are not. The purpose of this work is to provide estimates of direct medical expenditure for physician, drug, and hospital utilization among Medicaid-eligible women who screened as currently experiencing IPV compared with those who are not currently experiencing IPV. Methods. In this family practice-based cross-sectional study, women were screened for current IPV using a 15-item Index of Spouse Abuse-Physical (ISA-P) between 1997 and 1998. Consents were obtained from study subjects to review Medicaid expenditure and utilization data for the same time period. Results. Mean physician, hospital, and total expenditures were higher for those women with higher IPV scores compared with those who scored as not currently experiencing IPV, after adjusting for confounders. Higher IPV scores were associated with a three-fold increased risk of having a total expenditure over $5,000 (95% confidence interval [CI] 1.3, 8.4). The mean total expenditure difference between the high IPV and no IPV groups was $1,064 (95% Cl $623, $1506). The adjusted risk ratio for high IPV score and the log of total Medicaid expenditures was 2.3 (95% Cl 1.2, 4.4). Conclusions. Women screened as experiencing higher IPV scores had higher Medicaid expenditures compared with women not currently experiencing IPV Early IPV assessment partnered with effective clinic or community-based interventions may help to identify IPV earlier and reduce the health impact and cost of IPV.
引用
收藏
页码:557 / 567
页数:11
相关论文
共 50 条
  • [1] Trends in Medicaid prescribed drug expenditures and utilization
    Tepper, CD
    Lied, TR
    [J]. HEALTH CARE FINANCING REVIEW, 2004, 25 (03): : 69 - 78
  • [2] Medicaid nursing facility rates, capacity, utilization and expenditures
    Swan, J
    Harrington, C
    [J]. GERONTOLOGIST, 2002, 42 : 343 - 344
  • [3] Medicaid Prescription Drug Utilization and Expenditures Following Part D
    Farley, Joel F.
    Dusetzina, Stacie B.
    [J]. JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2010, 21 (02) : 715 - 728
  • [4] PHYSICIAN EXPENDITURES AND UTILIZATION FOR ELDERLY MEDICAID ENROLLEES IN 4 STATES
    BUCZKO, W
    [J]. GERONTOLOGIST, 1985, 25 : 111 - 111
  • [5] Methods for Estimating Medical Expenditures Attributable to Intimate Partner Violence
    Brown, Derek S.
    Finkelstein, Eric A.
    Mercy, James A.
    [J]. JOURNAL OF INTERPERSONAL VIOLENCE, 2008, 23 (12) : 1747 - 1766
  • [6] EVALUATING EXPENDITURES AND UTILIZATION OF OHIO'S INTEGRATED MEDICARE AND MEDICAID PROGRAM
    Bowblis, John
    Applebaum, Robert
    Nelson, Matt
    [J]. INNOVATION IN AGING, 2022, 6 : 187 - 187
  • [7] THE IMPACT OF STATE MEDICAID NURSING-HOME POLICIES ON UTILIZATION AND EXPENDITURES
    HARRINGTON, C
    SWAN, JH
    [J]. INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 1987, 24 (02) : 157 - 172
  • [8] HEALTHCARE UTILIZATION AND EXPENDITURES OF COMMERCIAL/MEDICARE AND MEDICAID PATIENTS WITH HIDRADENITIS SUPPURATIVA
    Kimball, A.
    Marvel, J.
    Vlahiotis, A.
    Willson, T. M.
    Sainski-Nguyen, A.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A161 - A162
  • [9] HIV ANTIRETROVIRAL DRUG UTILIZATION AND EXPENDITURES IN MEDICAID 1991-2014
    Alshehri, A.
    Seoane-Vazquez, E.
    Schneider, T.
    Rodriguez-Monguio, R.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A245 - A245
  • [10] INTIMATE PARTNER VIOLENCE AND ALCOHOL TREATMENT UTILIZATION
    Schonbrun, Y. C.
    Spillane, N. S.
    Orchowski, L. M.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2011, 35 (06) : 202A - 202A